dc.contributor.author | Hendrawati, Asri | |
dc.date.accessioned | 2019-03-25T02:43:40Z | |
dc.date.available | 2019-03-25T02:43:40Z | |
dc.date.issued | 2017-04-27 | |
dc.identifier.uri | http://hdl.handle.net/123456789/14323 | |
dc.description | Collections > Lecturers > Faculty of medicine > POSTER | en_US |
dc.description.abstract | Type 2 diabetes mellitus is a metabolic disease that often cause cardiomyopathy and heart failure. These complications are caused by free radicals increasing that induced expression of pro inflammatory genes nuclear factor kappa B (NF-KB) and causes cells damage. Quercetin is an antioxidant that can affect the expression of NF-KB and prevent cells damage. The combination of quercetin with oral hypoglycaemic drugs is expected to be a better therapy for type 2 diabetes.
The aim of this study is to measure the effects of quercetin and glibenclamide combination on cardiac muscle cells NF-KB expression in type 2 diabetic rats compared with no combination. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | SICEM | en_US |
dc.subject | diabetes mellitus, quercetin, glibenclamide | en_US |
dc.title | EFFECT OF QUERCETIN AND GLIBENCLAMIDE COMBINATION ON CARDIAC MUSCLE NUCLEAR FACTOR KAPPA B (NF-KB) EXPRESSION IN TYPE 2 DIABETIC RATS | en_US |
dc.type | Other | en_US |